Local Advanced Hepatocellular Carcinoma

1 clinical trials · Condition

Record	Firm	Date
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors (NCT06427941)	BeOne Medicines	2024-07-23

Every clearance here is in the API, with alerts when new ones post.